SBC Medical Group (NASDAQ:SBC - Get Free Report) is projected to post its Q2 2025 quarterly earnings results before the market opens on Wednesday, August 13th. Analysts expect SBC Medical Group to post earnings of $0.14 per share and revenue of $44.71 million for the quarter.
SBC Medical Group (NASDAQ:SBC - Get Free Report) last announced its earnings results on Thursday, May 15th. The company reported $0.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.11 by $0.10. The firm had revenue of $47.33 million during the quarter, compared to the consensus estimate of $51.52 million. On average, analysts expect SBC Medical Group to post $5 EPS for the current fiscal year and $6 EPS for the next fiscal year.
SBC Medical Group Stock Performance
Shares of NASDAQ:SBC traded up $0.17 during trading on Friday, hitting $4.40. The stock had a trading volume of 20,872 shares, compared to its average volume of 98,261. SBC Medical Group has a 12 month low of $2.62 and a 12 month high of $19.50. The firm's fifty day moving average is $4.69 and its 200 day moving average is $4.25. The company has a quick ratio of 4.40, a current ratio of 4.44 and a debt-to-equity ratio of 0.03.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in SBC Medical Group stock. Geode Capital Management LLC acquired a new stake in shares of SBC Medical Group Holdings Incorporated (NASDAQ:SBC - Free Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 98,082 shares of the company's stock, valued at approximately $455,000. Geode Capital Management LLC owned approximately 0.09% of SBC Medical Group as of its most recent SEC filing. 60.82% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Separately, Wall Street Zen raised SBC Medical Group to a "strong-buy" rating in a research report on Saturday, June 21st.
Get Our Latest Report on SBC Medical Group
About SBC Medical Group
(
Get Free Report)
SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand.
Further Reading
Before you consider SBC Medical Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SBC Medical Group wasn't on the list.
While SBC Medical Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
